We have expertise and infrastructure for handling varied chemistry technologies and special platforms. We have been serving customers worldwide on various complex platforms like peptides, steroids, carbohydrates, mPEGs, and High Potent APIs (HPAPIs) for over 2 decades.
The various specialized chemistry development and manufacturing technologies we serve are:
Peptides
Peptides are one of the fastest-growing therapeutic modalities. We have extensive experience in peptide development and manufacturing. We can help develop various classes of peptides such as:
- Linear and branched chain peptides up to 40 AA
- Derivatives of peptides viz. steroids/ small molecules/ lipids/ carbohydrate/ PEG, depsipeptides, peptides with multiple disulfides bridges, and stapled peptides.
- We also have access to unnatural amino acid building blocks via asymmetric hydrogenation
Our advanced technology with modern infrastructure enables us to produce up to 2 kg of linear and branched chain peptides using solid, solution, and hybrid phase techniques. We provide peptide manufacturing services from our state-of-the-art manufacturing site in Vizag. This site is inspected by major regulatory bodies such as the US FDA, MHRA, PMDA, etc.
We have extensive expertise and infrastructure for downstream purification of peptides using RPHPLCs with PAT tools and fully automated ion chromatography. Also, we have Hastelloy ANFDs for the closed loop filtration process. We are also backed by a strong analytical team and advanced analytical instrumentation supporting impurity profiling and characterization.
Steroids
We have worked on Steroid APIs for more than 2 decades. As one of the leading contract research organizations, we have developed and manufactured many legacy steroid assets for our customers. Our experience ranges across various types of human and veterinary classes of steroids including glucocorticoids, hormonal steroids, fluorinated steroids, and derivatives of steroids such as peptides, small molecules, lipids, carbohydrates, and PEGs.
We have a US FDA-inspected dedicated steroid facility in Cuernavaca, Mexico. Our facility has multiple modules with a Mix of SS, GL, and HastelloyC reactors that can handle up to 300 kg batch.
mPEGs
With varied applications, mPEG derivatives are one of the most promising therapeutic options available. We provide end-to-end services in mPEG derivatives from synthetic route design to incorporating the activating group, as per customer’s requirements for commercial manufacturing of mPEG alcohols and mPEG derivatives.
We specialize in linear activated mPEG derivatives typically with a wide range of molecular weights from 2 kDa to 40 kDa. What makes us uniquely positioned in mPEGs is our technical and analytical know-how and ready access and backward integration of mPEG alcohol. We manufacture mPEG alcohol at our Mexico site and manufacture mPEG derivatives in Hyderabad and Mirfield sites. All our sites are USFDA and other reputed regulatory bodies inspected.
Carbohydrates
While carbohydrates have the potential to develop various therapeutic drugs, there is an inherent structural complexity to developing these molecules. We have a rich track record of having worked on all classes of carbohydrates such as:
- Monosaccharides
- Polysaccharides
- Iminosugars
- Carbocyclic sugars
- Nucleosides
- Locked Nucleic Acids (LNA)
- Glycopeptides
- Thioglycosides
We have capabilities across complex multi-step carbohydrates involving:
- Linear & convergent synthesis
- Selective protection and deprotection
- Control of selectivity in moisture-sensitive glycosylation
- Handling of triflates, azide transfer, and oxidations
We also have hands-on experience in the use of glycosyl donors such as SMethyl and STolyl and have capabilities in downstream purification and isolation involving
Carbohydrates are manufactured in Hyderabad CTO-2 and Vizag CTO-6 and CTO-SEZ sites. Our sites are equipped to handle carbohydrate manufacturing at scale with operations such as telescoping at commercial scale and various types of purification such as
- C-18 Purification (up to 2 Kg of crude compounds)
- Gel Permeation Chromatography (GPC) purification and
- SAX (Strong Anion Exchange) purification
Our strength is our operational efficiency to remove chromatographic separation and use of simple techniques to limit impurities such as solubility and solvent-based extractions.
High potent small molecule development and manufacturing services
With the increasing prevalence of cancer, comes the need for more and more highly potent drugs. We offer highly potent small molecule development and manufacturing services for API and intermediates. The development lab is based out of Hyderabad and can handle molecules with OEL as low as 0.1 µ/m3 and with an output between 25 to 50 gms per batch.
We have one of the world’s largest capacities to manufacture highly potent compounds with OEL in the range of 0.1-1 μg/m³ (OEB 5). Our facilities are US FDA and other reputed regulatory agencies audited. We have the capability of handling high potent compounds, backed by special unit operations such as micronization and spray drying procedures. Our facility is designed to give output as low as 500 gm to multi-tons.
Why Aurigene Specialized Chemistry Services?
More than 2 decades of experience
US FDA-inspected labs and 8 US FDA inspected cGMP facilities
Analytical talent and infrastructure
Virtual Tour
Hyderabad R and D Center
Bangalore R and D Center
Connect with our scientific experts for your drug discovery, development, and manufacturing needs
We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.
Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.
Methoxy Polyethylene Glycol (m-PEGs)
Aurigene Pharmaceutical Services is a leader in the synthesis of activated MethoxyPolyethyleneGlycol(m-PEGs), With a comprehensive product range and customized services. ...
Read More
Base mediated spirocyclization of quinazoline: one-step synthesis of spiro-isoindolinone dihydroquinazolinones
2020
A novel approach for the spiro-isoindolinone dihydroquinazolinones has been demonstrated from 2- aminobenzamide and 2-cyanomethyl benzoate in the presence of KHMDS as a base to get moderate yields. The reaction has been screened in various bases followed by solvents and a gram scale reaction has also been executed under the given conditions. Based on the controll...
Read More-
Ultrasound assisted rapid synthesis of mefenamic acid based indole derivatives under ligand free Cu-catalysis: Their pharmacological evaluation
2005
An improved and rapid synthesis of mefenamic acid based indole derivatives has been achieved via the ligand free Cu-catalyzed coupling-cyclization method under ultrasound irradiation. This simple, straightforward and inexpensive one-pot method involved the reaction of a terminal alkyne derived from mefenamic acid with 2- iodosulfanilides in the presence of CuI ...
Read More -
Formal synthesis of Cladospolide C & epi-Cladospolide C using R- (þ)-g-valerolactone as a chiral synthon
2005
The formal synthesis of Cladospolide-C and its analog is achieved by using enantiopure (R)-g evalerolactone 10. The significant points of this synthesis are the stereoselective dihydroxylation of a, bunsaturated ester 16 using Sharpless protocol, Wittig olefination of g evalerolactol 6 with triphenylphosphonium iodide salt 7, one pot selective oxidation ...
Read More -
Amberlite-15 promoted an unprecedented aza Michael rearrangement for one pot synthesis of dihydroquinazolinone compounds
2005
A new one pot multicomponent annulation strategy for the synthesis of various dihydroquinazolinone compounds has been developed using Amberlite-15 as a catalyst, giving good to moderate yields. In this reaction the substrate scope for amines and aldehydes was also investigated. The reaction has been checked on a large scale ...
Read More
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market